LU88762I2 - Lanreotide et ses dérivés pharmaceutiquement acceptables (Somatuline (R)) - Google Patents

Lanreotide et ses dérivés pharmaceutiquement acceptables (Somatuline (R))

Info

Publication number
LU88762I2
LU88762I2 LU88762C LU88762C LU88762I2 LU 88762 I2 LU88762 I2 LU 88762I2 LU 88762 C LU88762 C LU 88762C LU 88762 C LU88762 C LU 88762C LU 88762 I2 LU88762 I2 LU 88762I2
Authority
LU
Luxembourg
Prior art keywords
alkyl
pharmaceutically acceptable
somatuline
lanreotide
acceptable derivatives
Prior art date
Application number
LU88762C
Other languages
English (en)
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of LU88762I2 publication Critical patent/LU88762I2/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/655Somatostatins
    • C07K14/6555Somatostatins at least 1 amino acid in D-form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
LU88762C 1985-09-12 1985-12-02 Lanreotide et ses dérivés pharmaceutiquement acceptables (Somatuline (R)) LU88762I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77548885A 1985-09-12 1985-09-12

Publications (1)

Publication Number Publication Date
LU88762I2 true LU88762I2 (fr) 1996-11-05

Family

ID=25104585

Family Applications (1)

Application Number Title Priority Date Filing Date
LU88762C LU88762I2 (fr) 1985-09-12 1985-12-02 Lanreotide et ses dérivés pharmaceutiquement acceptables (Somatuline (R))

Country Status (5)

Country Link
EP (1) EP0215171B1 (fr)
JP (1) JPH085913B2 (fr)
AT (1) ATE58542T1 (fr)
DE (1) DE3580674D1 (fr)
LU (1) LU88762I2 (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
DE3726517A1 (de) * 1986-08-18 1988-03-03 Sandoz Ag Nasale zusammensetzungen, welche octreotid enthalten
JP2568228B2 (ja) * 1987-02-03 1996-12-25 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ソマトスタチンアナログ
JP2809403B2 (ja) * 1987-07-07 1998-10-08 ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド 治療用ソマトスタチンアナログ化合物
DE3822557C2 (de) * 1987-07-10 1998-07-02 Ciba Geigy Ag Arzneimittel, enthaltend Somatostatine
US5089472A (en) * 1988-01-26 1992-02-18 Laboratorios Serono S.A. Use of growth hormone releasing factor for improving mental function
DE3910667A1 (de) * 1988-04-11 1989-10-19 Sandoz Ag Peptidderivate
CA2012115C (fr) * 1989-03-15 2001-07-03 Biomeasure, Inc. Somatostatines iodees
JPH0725786A (ja) * 1990-05-16 1995-01-27 Univ Rockefeller アルツハイマー病を伴うアミロイドーシスの治療
HU207104B (en) * 1991-01-25 1993-03-01 Biosignal Kutato Fejlesztoe Kf Process for producing new somatostatin analogs inhibiting tumour growth and pharmaceutical compositions comprising such compounds
ES2162822T3 (es) * 1992-07-27 2002-01-16 Univ Tulane Utilizacion de octapeptidos para el tratamiento de enfermedades asociadas con el receptor de neuromedina b.
US5569741A (en) * 1992-07-27 1996-10-29 Biomeasure, Inc. Cyclic octapeptide neuromedin B receptor antagonists
US5462926A (en) * 1992-07-27 1995-10-31 Biomeasure, Inc. Neuromedin B receptor antagonists which demonstrate selectivity
US5597894A (en) * 1995-06-05 1997-01-28 The Louisiana State University Medical Center Foundation Multi-tyrosinated somatostatin analogs
US6262229B1 (en) 1996-12-04 2001-07-17 Biomeasure Incorporated Somatostatin antagonists
PT2523653T (pt) 2010-01-13 2018-06-28 Ipsen Pharma Sas Processo para a preparação de composições farmacêuticas para a libertação prolongada de análogos de somatostatina
EP2399931A1 (fr) * 2010-06-22 2011-12-28 Ipsen Pharma S.A.S. Nouveaux composés octapeptidiques et leur utilisation thérapeutique

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19375086I2 (de) * 1979-11-27 2003-01-09 Novartis Ag Polypeptide Verfahren zu ihrer Herstellung pharmazeutische Zusammensetzungen die diese Polypeptide enthalten und ihre Verwendung
US4328135A (en) * 1980-06-13 1982-05-04 American Home Products Corporation Octapeptides lowering growth hormone
US4282143A (en) * 1980-06-13 1981-08-04 American Home Products Corporation Octapeptides lowering growth hormone
DK81082A (da) * 1981-03-06 1982-09-07 Sandoz Ag Fremgangsmaade til fremstilling af polypeptider
CH647246A5 (en) * 1981-03-06 1985-01-15 Sandoz Ag Polypeptide derivatives, their preparation and pharmaceutical products which contain these polypeptide derivatives
CH655505B (fr) * 1982-08-24 1986-04-30
US4684620A (en) * 1984-09-04 1987-08-04 Gibson-Stephens Neuropharmaceuticals, Inc. Cyclic polypeptides having mu-receptor specificity
US4725577A (en) * 1985-04-25 1988-02-16 Administrators Of The Tulane Educational Fund Biologically active lysine containing octapeptides
US4650787A (en) * 1985-04-25 1987-03-17 Schally Andrew Victor Biologically active octapeptides

Also Published As

Publication number Publication date
DE3580674D1 (en) 1991-01-03
EP0215171B1 (fr) 1990-11-22
EP0215171A2 (fr) 1987-03-25
JPH085913B2 (ja) 1996-01-24
EP0215171A3 (en) 1988-11-09
ATE58542T1 (de) 1990-12-15
JPS6261997A (ja) 1987-03-18

Similar Documents

Publication Publication Date Title
LU88762I2 (fr) Lanreotide et ses dérivés pharmaceutiquement acceptables (Somatuline (R))
ATE116306T1 (de) Hypoglykämische oxazolidindion-derivate.
CO4940479A1 (es) Derivados fenil y aminofenil-alquilsulfonamida y de urea
ATE65993T1 (de) Chinolinverbindung.
FI872555A0 (fi) Antiallergiska och antiinflammatoriska aemnen.
ES2064618T3 (es) Agonistas de serotonina de tetrahidrobenz(c,d)indol.
ATE87921T1 (de) Cycloalkylamide von (8beta)-1-alkyl-6(substituierten) ergolinen.
DE68921198D1 (de) Benzothiadiazepin-derivate.
ATE54151T1 (de) Erythromycylamin-derivate.
NO893039D0 (no) Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler.
ATE41421T1 (de) Carbonatderivate des ananasketons.
DK6284D0 (da) Heterocycliske forbindelser, fremgangsmade til deres fremstilling samt deres anvendelse
DE3664467D1 (de) Pineapple ketone l'alkoxyalkyl derivatives
JPS53129223A (en) Colored organic compound and its production
DK233186D0 (da) Thiophenonderivater samt deres fremstilling og anvendelse
ES8707500A1 (es) Procedimiento para la obtencion de isocianatos piperidinicos.